Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles
Please note that all translations are automatically generated. Click here for the English version.
5.4K Views
•
06:06 min
•
March 9th, 2019
DOI :
March 9th, 2019
•1Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, 2Respiratory Medicine Research Laboratory, Institute of Translation Medicine, Shanghai General Hospital, Shanghai Jiaotong University, 3Institute of Medical Science, Faculty of Medicine, University of Toronto
Rozdziały w tym wideo
0:04
Title
1:02
Preparation of Peptide Solutions
2:39
Formulation of GNP/PKCi and Assessment of GNP/PKCi Hybrid Solubility
4:13
Results: Analysis of the Gold Nanoparticle Protein Kinase C-delta Inhibitor
5:07
Conclusion
Powiązane Filmy
08:35
Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
28.0K Views
05:55
Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles
8.7K Views
10:46
Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
6.8K Views
09:06
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
1.4K Views
09:09
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
5.9K Views
07:58
Formulation and Characterization of Bioactive Agent Containing Nanodisks
1.0K Views
10:38
Synthesis of Functionalized 10-nm Polymer-coated Gold Particles for Endothelium Targeting and Drug Delivery
12.5K Views
10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
9.3K Views
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
4.9K Views
09:51
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
12.3K Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone